NIH to Address Unmet At-Home, PoC Testing Tech Needs
National Institute of Biomedical Imaging and Bioengineering
POCTRN to apply COVID-19 experience and expertise to develop testing, monitoring, and treating technologies
A novel liquid biopsy technology leverages cell-free RNA “dark matter” to enhance cancer diagnosis
The CREDENCE trial demonstrated how canagliflozin treatment brought down the levels of cardiorenal blood biomarkers
Certain plasma proteins may indicate the onset and risk of various mental health disorders